Herpes zoster vaccination in SLE: A pilot study of immunogenicity

Journal of Rheumatology

Volumn 40, Issue 11, 2013, Pages 1875-1880

  Guthridge, Joel M ^a   Cogman, Abigail ^a   Merrill, Joan T ^a   Macwana, Susan ^a   Bean, Krista M ^a   Powe, Tiny ^a   Roberts, Virginia ^a   James, Judith A ^a   Chakravarty, Eliza F ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

CLINICAL TRIAL; HERPES ZOSTER; INFECTION; SySTEMIC LUPUS ERyTHEMATOSUS; VACCINE; ZOSTAVAx

Indexed keywords

VARICELLA ZOSTER VACCINE; VIRUS ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HERPES ZOSTER; HUMAN; IMMUNOGENICITY; INJECTION SITE ERYTHEMA; INJECTION SITE REACTION; PILOT STUDY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; VACCINATION; VARICELLA ZOSTER VIRUS; VESICULAR RASH;

CLINICAL TRIAL; HERPES ZOSTER; INFECTION; SYSTEMIC LUPUS ERYTHEMATOSUS; VACCINE; ZOSTAVAX;

FEMALE; HERPES ZOSTER; HERPES ZOSTER VACCINE; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 84887452887     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.130170     Document Type: Article

References (25)

1. Levin MJ, Oxman N, Zhang JH, Johnson GR, Stanley H, Hayward AR, et al. Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. J Infect Dis 2008;197:825-35.
2. Chakravarty EF. Viral infection and reactivation in autoimmune diseases. Arthritis Rheum 2008;58:2949-57.
3. Park HB, Kim KC, Park JH, Kang Ty, Lee HA, Kim TH, et al. Association of reduced CD4 T cell responses specific to varicella zoster virus with high incidence of herpes zoster in patients with systemic lupus erythematosus. J Rheumatol 2004;31:2151-5.
4. Pope JE, Krizova A, Ouimet JM, Goodwin JL, Lankin M. Close association of herpes zoster reactivation and systemic lupus erythematosus (SLE) diagnosis: case-control study of patients with SLE or noninflammatory musculoskeletal disorders. J Rheumatol 2004;31:274-9.
5. Wolfe F, Michaud K, Chakravarty EF. Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders. Rheumatology 2006;45:1370-5.
6. Ishikawa O, Abe M, Miyachi y. Herpes zoster in Japanese patients with systemic lupus erythematosus. Clin Exp Dermatol 1999;24:327-8.
7. Manzi S, Kuller LH, Kutzer J, Pazin GJ, Sinacore J, Medsger TA Jr, et al. Herpes zoster in systemic lupus erythematosus. J Rheumatol 1995;22:1254-8.
8. Kahl LE. Herpes zoster infections in systemic lupus erythematosus: risk factors and outcome. J Rheumatol 1994;21:84-6.
9. Moutsopoulos HM, Gallagher JD, Decker JL, Steinberg AD. Herpes zoster in patients with systemic lupus erythematosus. Arthritis Rheum 1978;21:789-802.
10. Chakravarty EF, Michaud K, Katz R, Wolfe F. Increased incidence of herpes zoster among patients with systemic lupus erythematosus. Lupus 2013;22:238-44.
11. Chen HH, Chen yM, Chen TJ, Lan JL, Lin CH, Chen Dy. Risk of herpes zoster in patients with systemic lupus erythematosus: a three-year follow-up study using a nationwide population-based cohort. Clinics (Sao Paulo) 2011;66:1177-82.
12. Hata A, Kuniyoshi M, Ohkusa y. Risk of herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study. Infection 2011;39:537-44.
13. Borba EF, Ribeiro AC, Martin P, Costa LP, Guedes LK, Bonfa E. Incidence, risk factors, and outcomes of herpes zoster in systemic lupus erythematosus. J Clin Rheum 2010;16:119-22.
14. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005;352:2271-2.
15. US Food and Drug Administration. Approval letter - Zostavax. [Internet. Accessed August 16, 2013.] Available from: http://www.fda.gov/ BiologicsBloodVaccines/Vaccines/Approved Products/ucm248608.htm
16. Weinberg A, Chang JH, Oxman MN, Johnson GR, Hayward AR, Caulfield MJ, et al. Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. J Infect Dis 2009;200:1068-77.
17. Centers for Disease Control. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2008;57:RR-5.
18. van Assen S, Agmon-Levin N, Ilkayam O, Cervera R, Doran MF, Dougados M, et al. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 2011;70:414-22.
19. Curtis JR, Saag KG, Winthrop K. Update on herpes zoster (shingles) vaccine for autoimmune disease patients. [Internet. Accessed August 16, 2013.] American College of Rheumatology Hotline, September 21, 2012. Available from http:// www.rheumatology.org/Publications/Hotline/Update-on-Herpes- Zoster-(Shingles)-Vaccine-for-Autoimmune-Disease-Patients/
20. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
21. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 1992;35:630-40.
22. Petri M, Buyon J, Kalunian KC, Urowitz MB, Strand V, Merrill J, et al. Revision of the SELENA flare index [abstract]. Arthritis Rheum 2009;60 Suppl 10:902.
23. Lee PP, Lee TL, Ho MH, Wong WH, Lau yL. Herpes zoster in juvenile-onset lupus erythematosus: incidence, clinical characteristics and risk factors. Pediatr Infect Dis J 2006;25:728-32.
24. Drolet M, Brisson M, Levin MJ, Schmader KE, Oxman MN, Johnson RW, et al. A prospective study of the herpes zoster severity of illness. Clin J Pain 2010;26:656-66.
25. Wang TJ, Hu CC, Lin HC. Increased risk of anterior uveitis following herpes zoster: a nationwide population-based study. Arch Ophthalmol 2012;130:451-5.